4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001584759-26-000012
Director sold 300 shares at $12.00 ($3,600)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Heyman Richard A. Director | 2026-07-06 | Sale 10b5-1 | −300 | $12.00 | $3,600 | 212,772 | I: show line 1 in the form |
| Open-market sales · 300 sh · avg $12.00 · $3,600 | |||||||
Loading xslF345X06/form4-07082026_080727.xml…